Cargando…

Correction to: Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating c‐x‐c motif chemokine receptor 4

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626593/ http://dx.doi.org/10.1002/cac2.12210

Ejemplares similares

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4
por: He, Liru, et al.
Publicado: (2018)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury: Erratum
Publicado: (2023)

Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
por: Sun, Jiping, et al.
Publicado: (2022)

Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
por: Selenica, Maj-Linda B, et al.
Publicado: (2013)

Upregulation of C-X-C motif chemokine 12 in the spinal cord alleviated the symptoms of experimental autoimmune encephalomyelitis in Lewis rats
por: Lin, Dahe, et al.
Publicado: (2023)

Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort
por: Gong, Yi-Zhen, et al.
Publicado: (2021)

Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
por: Perez-Nievas, Beatriz G., et al.
Publicado: (2021)

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers
por: Miyake, Makito, et al.
Publicado: (2013)

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
por: MA, TENG, et al.
Publicado: (2015)

Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015)

A‐kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C‐X‐C motif) ligand 1/chemokine (C‐X‐C motif) ligand 2 in acute myeloid leukemia
por: Hao, Xiaohong, et al.
Publicado: (2019)

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis
por: Li, Yi‐Ming, et al.
Publicado: (2019)

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation
por: Yu, Baoqi, et al.
Publicado: (2016)

Gene Expression Profiles in Chemokine (C-C Motif) Ligand 21-Overexpressing Pancreatic Cancer Cells
por: Cui, Kai, et al.
Publicado: (2018)

Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Liang, Minrui, et al.
Publicado: (2016)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

Partial agonist activity of α(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3
por: Gao, Xianlong, et al.
Publicado: (2018)

Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer
por: Zhuo, Changhua, et al.
Publicado: (2018)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
por: Zhou, Jing, et al.
Publicado: (2021)

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
por: Wani, Nissar Ahmad, et al.
Publicado: (2014)

Evaluation of the influence of the C-X-C motif chemokine ligand 12 / C-X-C chemokine receptor 4 axis on canine mammary gland tumor cell migration
por: KUDO, Ayano, et al.
Publicado: (2023)

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
por: Li, Chunyan, et al.
Publicado: (2015)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
por: Wu, Qianmiao, et al.
Publicado: (2022)

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
por: Yan, Yali, et al.
Publicado: (2022)

Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1
por: Anzick, Sarah L, et al.
Publicado: (2003)

Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma
por: Cao, Zhongwei, et al.
Publicado: (2014)

Nobiletin enhances plasma Interleukin‐6 and C‐X‐C motif chemokine ligand 1 levels that are increased by treadmill running
por: Suzuki, Toshihide, et al.
Publicado: (2022)

Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations
por: Kishi, Hiroyuki, et al.
Publicado: (2016)

Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C–C Motif Chemokine Ligand 20
por: Luo, Yixin, et al.
Publicado: (2022)

C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
por: Yang, Xiao-Yan, et al.
Publicado: (2019)

C-X-C Motif Chemokine 10 Impairs Autophagy and Autolysosome Formation in Non-alcoholic Steatohepatitis
por: Zhang, Xiang, et al.
Publicado: (2017)

Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer
por: Ruan, Guo-Tian, et al.
Publicado: (2019)

Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2
por: Cho, Hee Seong, et al.
Publicado: (2023)

Collagen content and C-X-C motif chemokine ligand 12 expression in neoplastic breast stroma
por: Ferreira, Cindy Juliane da Silva, et al.
Publicado: (2023)

Chemokine C–C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice
por: Luciano-Mateo, Fedra, et al.
Publicado: (2020)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer
por: Saenz, FR, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_krelbpivmu7rgmqe6hv1aav9sn